IsoPlexis Obtains $300,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69e19ff4-462d-4619-b410-8221f2fea959 - Date
8/12/2014 - Company Name
IsoPlexis - Mailing Address
55 Whitney Ave. 2nd Floor New Haven, CT 06520 USA - Company Description
Our proprietary single-cell multiplexing micro-immunoassay and software enable new therapeutic and diagnostic discovery opportunities. Single cell analysis facilitates determination of cellular subsets among heterogeneous cancer and immune cell populations. - Website
http://www.isoplexis.com - Transaction Type
Venture Equity - Transaction Amount
$300,000 - Transaction Round
Undisclosed - Proceeds Purposes
The funding will help the company conduct engineering and software updates, finalize a beta version of its product, and support additional hospital and clinical case studies. It will also go toward product development and working capital. - M&A Terms
- Venture Investor
